More than just a picture

Quantitative brain image analysis could positively impact MS patient care

By Elizabeth Fisher
Senior Director, Research Technology, Biogen

January 17, 2017

Siemens Healthineers and Biogen plan to jointly develop magnetic resonance imaging (MRI) applications with the intent of quantifying key markers of multiple sclerosis (MS) disease activity and progression. Hear more about the project from Elizabeth Fisher, Senior Director, Research Technology.

Interested in a career in R&D at Biogen? Visit R&D Careers.

Related BiogenScience